Supporting Safe and Scalable Weight Loss Programs As clinics expand their GLP-1 offerings, maintaining consistent standards becomes increasingly important
I should have educated myself more, Gammon said
Continued lifestyle commitment It is important to note that both medications, tirzepatide and semaglutide, are most effective with a healthy lifestyle
Side Effects, Safety, and Treatment Considerations Semaglutide and retatrutide share the same side effects in terms of the most commonly reported adverse events: nausea, constipation, and gastrointestinal discomfort, particularly during dose escalation
Therefore, the following targets are recommended: 14 LDL-cholesterol less than 2.0 mmol/L (or less than 1.8 mmol/L if CV disease is established) HDL-cholesterol greater than 1.0 mmol/L triglycerides: less than 2.0 mmol/L
In an accompanying comment, Nauck and Horowitz (2026) highlight that this study should not be interpreted as demonstrating greater efficacy of orforglipron compared to semaglutide, since similar HbA 1c and weight reductions can be achieved with similar adverse event rates with the (not yet licensed in the UK) 25 mg and 50 mg doses of oral semaglutide (Aroda et al, 2023)